Biotechnology Changing Frugal Eating Habits – How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Brexit Impact On Drugs – Rising Shortages in UK Highlight Brexit Challenges – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), GSK (NYSE:GSK) Read more
Biotechnology German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats Why Is Animal Health Giant Zoetis Stock Tumbling On Friday? – Zoetis (NYSE:ZTS) Read more
Biotechnology One Good, One Bad News For Bristol Myers Squibb’s Marketed Drugs: Details – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology How Are Obesity Drugs And Nvidia Related? Success Of Ozempic, Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development – NVIDIA (NASDAQ:NVDA), Novo Nordisk (NYSE:NVO) Read more
Biotechnology Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology US Prescriptions Race For Weight Loss Drugs – Eli Lilly’s Zepbound Overtakes Novo Nordisk’s Wegovy – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Inconsistent Insurance Coverage For Weight Loss Drugs – Novo Nordisk’s GLP-1s Face Hurdles Despite Health Benefits – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly’s Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs – Agilent Technologies (NYSE:A), Avantor (NYSE:AVTR) Read more